Embargoed: 0700hrs 30 October 2006 Akers Biosciences Inc. ("Akers" or the "Company") Major Distribution Agreement Thorofare, NJ, USA-October 30, 2006--Akers Biosciences Inc. (LSE:AKR) is pleased to announce that it has signed an agreement with Pulse Marketing Corp. ("Pulse") of Portland, Oregon, USA for the marketing and distribution of Akers' home cholesterol and free radical tests to direct sales companies, most of whom are members of the Direct Selling Association. The agreement includes development funds to be paid to Akers to modify the tests to Pulse's specifications, and then provides for manufacturing of the products by Akers for Pulse. Pulse, whose distribution reaches over 1 million independent business owners in North America alone, intends to market the products as soon as the development phase is completed, which is targeted for March 2007. Until now Akers has not marketed these products in the U.S. to the direct sales marketplace. This agreement with Pulse will significantly increase the number of representatives marketing the product and the regions in which Akers is able to penetrate. Dr. Ray Akers, CEO of Akers Biosciences said, "Today's agreement represents a significant step in our strategy to penetrate a large segment of the U.S. home healthcare market. There is a clear medical need for our breakthrough tests for cholesterol and free radicals, and this agreement fits nicely with the trends in wellness and health awareness among U.S. consumers. This alliance with Pulse Marketing will make our product more widely available to consumers across the U.S., and will significantly increase our share of voice in the marketplace." Information on the Tri-Cholesterol and Free Radical Tests Cholesterol levels are directly related to the risk of cardiovascular disease. The Tri-Cholesterol Test Kit is the only FDA-approved rapid assay that provides a complete cholesterol profile of the patient, with semi-quantitative determinations of high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and total cholesterol levels in whole blood obtained from a finger stick. This complete cholesterol test panel has been designed in a test card format; an enzymatic color reaction from a single drop of blood produces results in approximately three minutes. Akers will modify the test under this agreement to work with a non-invasive sample, such as transdermal fluid or saliva, instead of whole blood. The Free Radical test measures the level of lipid peroxides in urine, which is an indication of free radical activity in a person's metabolism. Free radicals are associated with many disease processes, including cardiovascular, neurological, and immune systems diseases. Elevated levels of lipid peroxides indicate a need for increased levels of anti-oxidants, which can be provided in certain nutritional supplements. Pulse Marketing Corp. Pulse, and its affiliate Beanstalk Partners, are leading marketing organizations for direct selling companies such as Quixtar Inc., Melaleuca, Inc., Mannatech, Inc., and PrePaid Legal, Inc. Pulse distributes products into these organizations, and creates the sales and marketing initiatives for these companies. Pulse's products reach over 1 million independent business owners in North America alone. Akers Biosciences Akers Biosciences, Inc. develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the patient or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. Akers has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com. Enquiries: Dr. Ray Akers Chief Executive Officer, Akers Biosciences, 020 7917 9476 Inc. Paul Freedman 001 856 848 8698 Chief Financial Officer, Akers Biosciences, Inc. Xavier DeMol Robert W. Baird, Ltd. 020 7667 8246 Bill Roberts CTC, Inc. 001 937 434 2700 Ben Simons Hansard Communications 020 7245 1100 END -0- Oct/30/2006 7:01 GMT
AKERS BIOSCIENCES INC: Distribution Agreement
Press spacebar to pause and continue. Press esc to stop.